Last update 08 May 2025

Clade C gp140 plus adjuvant(Janssen Vaccines & Prevention)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Immune System DiseasesInfectious DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
HIV Infections
Originator Organization
Janssen Vaccines & Prevention BV
Active Organization-
Inactive Organization
Janssen Vaccines & Prevention BV
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Clade C gp140 plus adjuvant(Janssen Vaccines & Prevention)
NCT02935686
/ CompletedPhase 1/2
A Randomized, Parallel-group, Placebo-controlled, Double-blind Phase 1/2a Study in Healthy HIV Uninfected Adults to Assess Safety/Tolerability and Immunogenicity of 2 Different Prime/Boost Regimens: Priming With Tetravalent Ad26.Mos4.HIV and Boosting With Tetravalent Ad26.Mos4.HIV and Either Clade C gp140 Plus Adjuvant OR a Combination of Mosaic and Clade C gp140 Plus Adjuvant
100 Clinical Results associated with Clade C gp140 plus adjuvant(Janssen Vaccines & Prevention)
Login to view more data
100 Translational Medicine associated with Clade C gp140 plus adjuvant(Janssen Vaccines & Prevention)
Login to view more data
100 Patents (Medical) associated with Clade C gp140 plus adjuvant(Janssen Vaccines & Prevention)
Login to view more data
100 Deals associated with Clade C gp140 plus adjuvant(Janssen Vaccines & Prevention)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 2
Rwanda
Janssen Vaccines & Prevention BV
31 Mar 2017
HIV InfectionsPhase 2
Kenya
Janssen Vaccines & Prevention BV
31 Mar 2017
HIV InfectionsPhase 2
United States
Janssen Vaccines & Prevention BV
31 Mar 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free